SREBF1 and prostate cancer: Li et al. has recently found that fatostatin induces apoptotic cell death in prostate cancer cells involving SREBP1-dependent caspase-3/7 enzymatic activity [15], suggesting that SREBP1 might regulate caspase 3/7 activity and cell apoptosis in bladder cancer cells.